Total Payments
$5,074
2024 Payments
$433.03
Companies
10
Transactions
233
Medicare Patients
288
Medicare Billing
$60,341
Payment Breakdown by Category
Food & Beverage$5,074 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,074 | 233 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,900 | 185 | $0 (2024) |
| GlaxoSmithKline, LLC. | $277.53 | 18 | $0 (2023) |
| Amgen Inc. | $238.55 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $199.65 | 5 | $0 (2023) |
| ITI, Inc. | $179.03 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $112.19 | 8 | $0 (2023) |
| Alkermes, Inc. | $105.14 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.96 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $17.76 | 1 | $0 (2021) |
| Axsome Therapeutics, Inc. | $14.19 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.03 | 6 | Amgen Inc. ($238.55) |
| 2023 | $1,033 | 52 | ABBVIE INC. ($829.20) |
| 2022 | $1,980 | 92 | AbbVie Inc. ($1,726) |
| 2021 | $1,628 | 83 | AbbVie Inc. ($1,151) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: Inflammation | ||||||
| 02/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $117.90 | General |
| Category: Cardiology | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: CNS | ||||||
| 06/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 55 | 85 | $17,670 | $6,291 |
| 2022 | 2 | 53 | 137 | $33,075 | $10,966 |
| 2021 | 2 | 72 | 217 | $47,145 | $18,089 |
| 2020 | 2 | 108 | 331 | $67,021 | $24,994 |
Total Patients
288
Total Services
770
Medicare Billing
$60,341
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 51 | $10,803 | $3,697 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,701 | $1,770 | 37.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 12 | 17 | $2,166 | $823.48 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 91 | $19,361 | $6,153 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 46 | $13,714 | $4,813 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 167 | $33,657 | $12,771 | 37.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 50 | $13,488 | $5,319 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 196 | $34,757 | $12,748 | 36.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 49 | 135 | $32,264 | $12,246 | 38.0% |
About John Armbruster, FNP
John Armbruster, FNP is a Family healthcare provider based in Bloomfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1003207242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Armbruster, FNP has received a total of $5,074 in payments from pharmaceutical and medical device companies, with $433.03 received in 2024. These payments were reported across 233 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($5,074).
As a Medicare-enrolled provider, Armbruster has provided services to 288 Medicare beneficiaries, totaling 770 services with total Medicare billing of $60,341. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Bloomfield, MO
- Active Since 02/10/2015
- Last Updated 08/08/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1003207242
Products in Payments
- UBRELVY (Drug) $2,213
- VRAYLAR (Drug) $790.46
- QULIPTA (Drug) $492.77
- MAVYRET (Drug) $395.24
- TRELEGY ELLIPTA (Drug) $264.74
- CAPLYTA (Drug) $179.03
- FARXIGA (Drug) $154.29
- Otezla (Drug) $120.65
- Repatha (Biological) $117.90
- ARISTADA (Drug) $105.14
- ABILIFY MAINTENA (Drug) $59.90
- REXULTI (Drug) $52.29
- BREZTRI (Drug) $45.36
- SPIRIVA RESPIMAT (Drug) $29.96
- NURTEC ODT (Drug) $17.76
- Auvelity (Drug) $14.19
- ANORO ELLIPTA (Drug) $12.79
- LINZESS (Drug) $8.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bloomfield
Sheila Armbruster, Fnp-C, FNP-C
Family — Payments: $4,381
Family $4,381
Lisa Fritch, Aprn, APRN
Family — Payments: $2,970
Family $2,970
Mrs. Jody Root, Fnp-Bc, FNP-BC
Family — Payments: $1,917
Family $1,917
Mr. Scott Masullo, Np, NP
Family — Payments: $1,701
Family $1,701
Dr. Shaina Barr
Family — Payments: $1,206
Family $1,206
Miriam Joseph
Family — Payments: $984.18
Family $984.18